Unknown EARLY_PHASE1 INTERVENTIONAL 2-arm NCT04728308

Bupivacaine Infiltration and Postoperative Pain

Does Bupivacaine Infiltration Reduce Postoperative Pain in Patients With Cesarean Section?

Sponsor: Armed Forces Hospital, Pakistan

Conditions Analgesia Local Infiltration Postoperative Pain

Interventions Bupivacain

Updated 5 times since 2021 Last updated: Jan 29, 2021 Started: Jan 10, 2021 Primary completion: Apr 10, 2021 Completion: Apr 10, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04728308, this EARLY_PHASE1 trial focuses on Analgesia and Local Infiltration and remains ongoing. Sponsored by Armed Forces Hospital, Pakistan, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown EARLY_PHASE1

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status EARLY_PHASE1

Status: Recruiting → Unknown Status
Mar 2021 — Feb 2023 [monthly]

Recruiting EARLY_PHASE1
Feb 2021 — Mar 2021 [monthly]

Recruiting EARLY_PHASE1

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Armed Forces Hospital, Pakistan

Data source: Armed Forces Hospital, Pakistan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Islamabad, Pakistan